EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis

Junhui Wang, Yannan Yang, Zehui Chen

Frontiers in Medicine · 03.07.2026 · 13

DOI: 10.3389/fmed.2026.1852035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 03.07.2026. Verfasst von Junhui Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guang'AnMen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Palmoplantar pustulosis (PPP) is a chronic inflammatory dermatosis with limited therapeutic options. Traditional Chinese Medicine (TCM) formulations may benefit PPP, yet microbiome-immune mechanisms underlying clinical response remain unclear.

Objectives

To evaluate whether an 8-week standardized Qingpao Chushi Jiedu Fang (QCF) regimen is associated with coordinated changes in clinical severity, oral microbiota, and circulating cytokines in PPP.

Methods

Thirty PPP patients received an 8-week standardized Qingpao Chushi Jiedu Fang (QCF) regimen. Clinical severity (PPPASI, Palmoplantar Pustulosis Area and Severity Index; Dermatology Life Quality Index, DLQI; pruritus/pain Visual Analogue Scale, VAS), oral microbiota (16S rDNA sequencing), and serum cytokines (IL-1β, IL-4, IFN- α , IFN- γ ) were assessed before and after treatment. Subgroup analyses were performed by smoking status.

Results

PPPASI significantly decreased from week 2 onward ( p < 0.001), with further improvement at weeks 4 and 8, while week-6 vs. week-4 changes were non significant ( p > 0.05). DLQI declined significantly at weeks 4–8 ( p < 0.05). Pain scores showed improvement only at week 6 vs. week 2 ( p < 0.05), and itch scores improved at week 8 ( p < 0.05). Oral microbial α - and β -diversity shifted significantly after treatment ( p < 0.05), with clear changes in community structure and taxa; smokers exhibited more pronounced restructuring. Cytokine levels changed concordantly, with IL-1β, IL-4, and IFN- α decreasing and IFN- γ increasing after treatment (all p < 0.05).

Conclusion

QCF treatment was associated with significant clinical improvement accompanied by oral microbiota remodeling and modulation of inflammatory cytokines. These findings support a potential microbiome-immune axis in PPP and warrant further controlled studies. Clinical trial registration http://www.itmctr.org , ITMCTR2025001530.

Schlagwörter

Stichwörter der Autor:innen

16S rDNAclinical trialdampness-resolving and detoxifying methodoral microbiomepalmoplantar pustulosistraditional Chinese medicine

Autor:innen und Institutionen

  • Guang'AnMen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

Zitieren

APA

Wang, J., Yang, Y., & Chen, Z. (2026). Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1852035

Vancouver

Wang J, Yang Y, Chen Z. Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1852035

BibTeX
@article{Wang2026,
  author = {Wang, Junhui and Yang, Yannan and Chen, Zehui},
  title = {Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1852035}
}
Kostenlos starten →